Base Laboratories Lidocaine Cream - Topical Anesthetic Pain Relief

Base Laboratories Lidocaine Anesthetic Pain Relief by

Drug Labeling and Warnings

Base Laboratories Lidocaine Anesthetic Pain Relief by is a Otc medication manufactured, distributed, or labeled by Joonem LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BASE LABORATORIES LIDOCAINE ANESTHETIC PAIN RELIEF- lidocaine cream 
Joonem LLC

----------

Base Laboratories Lidocaine Cream - Topical Anesthetic Pain Relief

Drug Facts

Active Ingredients

Lidocaine 4%

Purpose

Topical Analgesic

Indications:

Temporary relieves minor pain

Warnings:

For external use only

  • Avoid contact with the eyes.
  • If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a physician 
  • Do not apply to wounds or damaged skin.
  • Do not bandage tightly.

Do not use

  • in large quantities, particularly over raw surfaces or blistered areas.

Keep out of reach of children 

to avoid accidental ingestion!

If swallowed, get medical help or contact the poison control center immediately.

Directions:

  • use only as directed 
  • adults and children 12 years of age and older: apply to affected area not more than 3 to 4 times daily
  • children under 12 years of age: consult a doctor 

Other information:

Store at 20 to 25 C (68 to 77 F)

Inactive Ingredients:

Hemp Seed Oil, Aloe Vera Extract, Chamomile Extract, Glycerol, Cetearyl Alcohol, Cetearyl Glucoside, Propylene Glycol, Laurocapram, Stearic Acid, Glyceryl Stearate, PEG-100, EDTA, Cetyl Alcohol, Triethanolamine, Water

Package Labeling:

Tube0

BASE LABORATORIES LIDOCAINE ANESTHETIC PAIN RELIEF 
lidocaine cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 80327-010
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE40 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CANNABIS SATIVA SEED OIL (UNII: 69VJ1LPN1S)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
CHAMOMILE (UNII: FGL3685T2X)  
GLYCERIN (UNII: PDC6A3C0OX)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
CETEARYL GLUCOSIDE (UNII: 09FUA47KNA)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
LAUROCAPRAM (UNII: 1F3X9DRV9X)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
POLYETHYLENE GLYCOL 4500 (UNII: TVH7653921)  
EDETIC ACID (UNII: 9G34HU7RV0)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
TROLAMINE (UNII: 9O3K93S3TK)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 80327-010-601 in 1 CARTON08/31/202205/01/2025
160 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01708/31/202205/01/2025
Labeler - Joonem LLC (117633878)

Revised: 7/2025
Document Id: 3ac65314-c076-2de2-e063-6394a90ad3ca
Set id: e7b4ddd0-4380-f43d-e053-2995a90ac753
Version: 5
Effective Time: 20250725
Â
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.